122 related articles for article (PubMed ID: 9701213)
1. Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma.
Rijken AM; van Gulik TM; Polak MM; Sturm PD; Gouma DJ; Offerhaus GJ
J Surg Oncol; 1998 Jul; 68(3):187-92. PubMed ID: 9701213
[TBL] [Abstract][Full Text] [Related]
2. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.
Malats N; Porta M; Piñol JL; Corominas JM; Rifà J; Real FX
J Clin Oncol; 1995 Jul; 13(7):1679-86. PubMed ID: 7602358
[TBL] [Abstract][Full Text] [Related]
3. K-ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters.
Yamanaka S; Tomioka T; Tajima Y; Okada K; Shiku H; Kanematsu T
J Surg Oncol; 1997 Oct; 66(2):97-103. PubMed ID: 9354164
[TBL] [Abstract][Full Text] [Related]
4. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.
Imai M; Hoshi T; Ogawa K
Cancer; 1994 Jun; 73(11):2727-33. PubMed ID: 8194013
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
6. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
Hruban RH; Sturm PD; Slebos RJ; Wilentz RE; Musler AR; Yeo CJ; Sohn TA; van Velthuysen ML; Offerhaus GJ
Am J Pathol; 1997 Oct; 151(4):943-9. PubMed ID: 9327727
[TBL] [Abstract][Full Text] [Related]
7. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
Wattanasirichaigoon S; Tasanakhajorn U; Jesadapatarakul S
J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030
[TBL] [Abstract][Full Text] [Related]
8. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing.
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Cancer; 1990 Sep; 66(5):930-5. PubMed ID: 2167148
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
Ito R; Tamura K; Ashida H; Nishiwaki M; Nishioka A; Yamamoto Y; Furuyama JI; Utsunomiya J
Int J Oncol; 1998 May; 12(5):1019-23. PubMed ID: 9538122
[TBL] [Abstract][Full Text] [Related]
11. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
13. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
14. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H
Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644
[TBL] [Abstract][Full Text] [Related]
16. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
[TBL] [Abstract][Full Text] [Related]
17. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
18. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
19. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.
Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E
Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
